SEC Form 4 · accession 0001203311-16-000104
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Officer — President and CEO · Director
Period of report
May 25, 2016
Accepted (ET)
May 27, 2016 · 7:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2016 | M | 7,768 | $10.20 | A | 563,883 | D | |
| Common StockF2,F3 | May 25, 2016 | S | 7,768 | $40.5105 | D | 556,115 | D | |
| Common Stock | May 25, 2016 | M | 28,970 | $10.29 | A | 585,085 | D | |
| Common StockF2,F3 | May 25, 2016 | S | 28,970 | $40.5105 | D | 556,115 | D | |
| Common Stock | May 26, 2016 | M | 1,130 | $10.29 | A | 557,245 | D | |
| Common StockF2,F3 | May 26, 2016 | S | 1,130 | $40.0743 | D | 556,115 | D | |
| Common Stock | May 27, 2016 | M | 10,792 | $10.29 | A | 566,907 | D | |
| Common StockF2,F3 | May 27, 2016 | S | 10,792 | $40.1047 | D | 556,115 | D | |
| Common Stock | holding | — | — | — | 27,945 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $10.20 | May 25, 2016 | M | 7,768 | D | — | May 25, 2017 | Common Stock | 7,768 | 47,701 | D |
| Non-Qualified Stock Option (right to buy)F5 | $10.29 | May 25, 2016 | M | 28,970 | D | — | Aug 28, 2017 | Common Stock | 28,970 | 169,057 | D |
| Non-Qualified Stock Option (right to buy)F5 | $10.29 | May 26, 2016 | M | 1,130 | D | — | Aug 28, 2017 | Common Stock | 1,130 | 167,927 | D |
| Non-Qualified Stock Option (right to buy)F5 | $10.29 | May 27, 2016 | M | 10,792 | D | — | Aug 28, 2017 | Common Stock | 10,792 | 157,135 | D |
Explanation of responses
- F1The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan.
- F2Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
- F3Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F4Shares vested at a rate of 25% on 5/25/08 and monthly thereafter until all the shares were fully vested on 5/25/11.
- F5Shares vested at a rate of 25% on 8/28/08 and monthly thereafter until all the shares were fully vested on 8/28/11.